stockrowAbsci Corporation (ABSI) vs Generate Biomedicines, Inc. (GENB)
- Absci Corporation ABSI 10.17 +8.31%
- Generate Biomedicines, Inc. GENB 13.06 +3.90%
Absci Corporation and Generate Biomedicines, Inc. are both Biotechnology companies. Absci Corporation and Generate Biomedicines, Inc. are of similar size ($1.6B and $1.6B). Generate Biomedicines, Inc. has the higher net margin (−781.1% vs −7,756.4%) and the higher return on invested capital (0.00% vs −174.7%). Across the 15 metrics below, Generate Biomedicines, Inc. leads on 9 and Absci Corporation on 6.
Valuation
Profitability
| Metric | ABSI | GENB | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 68.51% |
| Operating margin | (8,084.50%) | (751.19%) | 0.00% |
| Net margin | (7,756.37%) | (781.10%) | 0.00% |
| Free cash flow margin | (6,969.83%) | (1,692.17%) | 0.00% |
| Return on equity | (57.72%) | 0.00% | (51.96%) |
| Return on assets | (50.57%) | (90.35%) | (46.06%) |
| Return on invested capital | (174.74%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack